FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 101 through 150 of 338

BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES - SIC # 2836

Ticker Exchange Company Financial Reports SIC #
CRGX Nasdaq CARGO Therapeutics, Inc. 2836
CRNX Nasdaq Crinetics Pharmaceuticals, Inc. 2836
CRSP Nasdaq CRISPR Therapeutics AG 2836
CRVO Nasdaq CervoMed Inc. 2836
CRVS Nasdaq Corvus Pharmaceuticals, Inc. 2836
CSCI Nasdaq COSCIENS Biopharma Inc. 2836
CSLLY Over the counter CSL Limited 2836
CTMX Nasdaq CytomX Therapeutics, Inc. 2836
CUE Nasdaq Cue Biopharma, Inc. 2836
CVAC Nasdaq CureVac N.V. 2836
CVKD Nasdaq Cadrenal Therapeutics, Inc. 2836
CVM NYSE American CEL-SCI Corporation 2836
CYCC Nasdaq Cyclacel Pharmaceuticals, Inc. 2836
DAWN Nasdaq Day One Biopharmaceuticals, Inc. 2836
DMAC Nasdaq DiaMedica Therapeutics Inc. 2836
DNTH Nasdaq Dianthus Therapeutics, Inc. 2836
DRMA Nasdaq Dermata Therapeutics, Inc. 2836
DRRX Nasdaq DURECT Corporation 2836
DRUG Nasdaq Bright Minds Biosciences Inc. 2836
DSGN Nasdaq Design Therapeutics, Inc. 2836
DTIL Nasdaq Precision BioSciences, Inc. 2836
DWTX Nasdaq Dogwood Therapeutics, Inc. 2836
DYN Nasdaq Dyne Therapeutics, Inc. 2836
EBS New York Emergent BioSolutions Inc. 2836
EDIT Nasdaq Editas Medicine, Inc. 2836
ELEV Nasdaq Elevation Oncology, Inc. 2836
ELUT Nasdaq Elutia Inc. 2836
ELVN Nasdaq Enliven Therapeutics, Inc. 2836
ENGN Nasdaq enGene Holdings Inc. 2836
ENTA Nasdaq Enanta Pharmaceuticals, Inc. 2836
ENTX Nasdaq Entera Bio Ltd. 2836
EPIX Nasdaq ESSA Pharma Inc. 2836
EQ Nasdaq Equillium, Inc. 2836
ERAS Nasdaq Erasca, Inc. 2836
ERNA Nasdaq Ernexa Therapeutics Inc. 2836
EXEL Nasdaq Exelixis, Inc. 2836
EXOZ Nasdaq eXoZymes, Inc. 2836
FBIO Nasdaq Fortress Biotech, Inc. 2836
FENC Nasdaq Fennec Pharmaceuticals Inc. 2836
FGEN Nasdaq FibroGen, Inc. 2836
FNCH Over the counter Finch Therapeutics Group, Inc. 2836
FOLD Nasdaq Amicus Therapeutics, Inc. 2836
FULC Nasdaq Fulcrum Therapeutics, Inc. 2836
GELS Nasdaq Gelteq Limited 2836
GHRS Nasdaq GH Research PLC 2836
GILD Nasdaq Gilead Sciences, Inc. 2836
GLMD Nasdaq Galmed Pharmaceuticals Ltd. 2836
GLSI Nasdaq Greenwich LifeSciences, Inc. 2836
GMAB Nasdaq Genmab A/S 2836
GNFT Nasdaq Genfit S.A. 2836
Results 100 through 150 of 338